Skip to main content
Erschienen in: World Journal of Urology 3/2016

01.03.2016 | Original Article

Comparison of renal function detriments after local tumor ablation or partial nephrectomy for renal cell carcinoma

verfasst von: Alessandro Larcher, Malek Meskawi, Roger Valdivieso, Katharina Boehm, Vincent Trudeau, Zhe Tian, Nicola Fossati, Paolo Dell’Oglio, Giovanni Lughezzani, Nicolò Buffi, Maxine Sun, Pierre Karakiewicz

Erschienen in: World Journal of Urology | Ausgabe 3/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Local tumor ablation (LTA) and partial nephrectomy (PN) represent treatment alternatives for patients diagnosed with small renal mass and both may result in renal function detriments. The aim of the study was to compare renal function detriments after LTA or PN.

Methods

A Surveillance epidemiology and End Results-Medicare-linked retrospective cohort of 2850 T1 kidney cancer patients who underwent LTA or PN was abstracted. Short-term outcomes consisted of 30-day acute kidney injury (AKI) and 30-day dialysis rates. Long-term outcomes consisted of episodes of AKI, mild and moderate–severe chronic kidney disease (CKD), end-stage renal disease, hemodialysis and anemia in CKD. Analyses consisted of propensity score matching, logistic and Cox regression.

Results

After propensity score matching, 1122 patients remained. The 30-day incidence of AKI was 4.6 % after LTA and 9.4 % after PN. In multivariable analyses (MVAs), LTA was associated with a lower AKI rate (OR 0.42; p = 0.001). The 30-day incidence of any dialysis was <2 % after either LTA or PN. In MVA, LTA was not associated with a lower rate of any dialysis (OR 0.43; p = 0.2). At long-term assessment, both the unadjusted and adjusted rates of all six examined end points were not different between LTA and PN (all p > 0.5).

Conclusions

LTA offers short-term protective effect from AKI. The short-term rates of any dialysis treatment are similar after either LTA or PN. At long-term assessment, LTA and PN renal function detriment rates are not different. Concern for long-term functional outcomes should not be a barrier for PN.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351:1296–1305CrossRefPubMed Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351:1296–1305CrossRefPubMed
2.
Zurück zum Zitat Eckardt KU, Coresh J, Devuyst O et al (2013) Evolving importance of kidney disease: from subspecialty to global health burden. Lancet 382:158–169CrossRefPubMed Eckardt KU, Coresh J, Devuyst O et al (2013) Evolving importance of kidney disease: from subspecialty to global health burden. Lancet 382:158–169CrossRefPubMed
3.
Zurück zum Zitat Network National Comprehensive Cancer, Cancer Kidney (2014) Version 2:2014 Network National Comprehensive Cancer, Cancer Kidney (2014) Version 2:2014
5.
Zurück zum Zitat Turna B, Kaouk JH, Frota R et al (2009) Minimally invasive nephron sparing management for renal tumors in solitary kidneys. J Urol 182:2150–2157CrossRefPubMed Turna B, Kaouk JH, Frota R et al (2009) Minimally invasive nephron sparing management for renal tumors in solitary kidneys. J Urol 182:2150–2157CrossRefPubMed
6.
Zurück zum Zitat Mues AC, Korets R, Graversen JA et al (2012) Clinical, pathologic, and functional outcomes after nephron-sparing surgery in patients with a solitary kidney: a multicenter experience. J Endourol 26:1361–1366PubMedCentralCrossRefPubMed Mues AC, Korets R, Graversen JA et al (2012) Clinical, pathologic, and functional outcomes after nephron-sparing surgery in patients with a solitary kidney: a multicenter experience. J Endourol 26:1361–1366PubMedCentralCrossRefPubMed
7.
Zurück zum Zitat Lucas SM, Stern JM, Adibi M, Zeltser IS, Cadeddu JA, Raj GV (2008) Renal function outcomes in patients treated for renal masses smaller than 4 cm by ablative and extirpative techniques. J Urol 179:75–79 discussion 9–80 CrossRefPubMed Lucas SM, Stern JM, Adibi M, Zeltser IS, Cadeddu JA, Raj GV (2008) Renal function outcomes in patients treated for renal masses smaller than 4 cm by ablative and extirpative techniques. J Urol 179:75–79 discussion 9–80 CrossRefPubMed
8.
Zurück zum Zitat Kiriluk KJ, Shikanov SA, Steinberg GD, Shalhav AL, Lifshitz DA (2011) Laparoscopic partial nephrectomy versus laparoscopic ablative therapy: a comparison of surgical and functional outcomes in a matched control study. J Endourol 25:1867–1872CrossRefPubMed Kiriluk KJ, Shikanov SA, Steinberg GD, Shalhav AL, Lifshitz DA (2011) Laparoscopic partial nephrectomy versus laparoscopic ablative therapy: a comparison of surgical and functional outcomes in a matched control study. J Endourol 25:1867–1872CrossRefPubMed
9.
Zurück zum Zitat Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF (2002) Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care 40:IV-3–IV-18 Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF (2002) Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care 40:IV-3–IV-18
10.
Zurück zum Zitat Miller DC, Saigal CS, Warren JL et al (2009) External validation of a claims-based algorithm for classifying kidney-cancer surgeries. BMC Health Serv Res 9:92PubMedCentralCrossRefPubMed Miller DC, Saigal CS, Warren JL et al (2009) External validation of a claims-based algorithm for classifying kidney-cancer surgeries. BMC Health Serv Res 9:92PubMedCentralCrossRefPubMed
11.
Zurück zum Zitat Sun M, Abdollah F, Liberman D et al (2011) Racial disparities and socioeconomic status in men diagnosed with testicular germ cell tumors: a survival analysis. Cancer 117:4277–4285CrossRefPubMed Sun M, Abdollah F, Liberman D et al (2011) Racial disparities and socioeconomic status in men diagnosed with testicular germ cell tumors: a survival analysis. Cancer 117:4277–4285CrossRefPubMed
12.
Zurück zum Zitat Klabunde CN, Potosky AL, Legler JM, Warren JL (2000) Development of a comorbidity index using physician claims data. J Clin Epidemiol 53:1258–1267CrossRefPubMed Klabunde CN, Potosky AL, Legler JM, Warren JL (2000) Development of a comorbidity index using physician claims data. J Clin Epidemiol 53:1258–1267CrossRefPubMed
13.
Zurück zum Zitat Sun M, Bianchi M, Trinh QD et al (2013) Comparison of partial vs radical nephrectomy with regard to other-cause mortality in T1 renal cell carcinoma among patients aged ≥75 years with multiple comorbidities. BJU Int 111:67–73CrossRefPubMed Sun M, Bianchi M, Trinh QD et al (2013) Comparison of partial vs radical nephrectomy with regard to other-cause mortality in T1 renal cell carcinoma among patients aged ≥75 years with multiple comorbidities. BJU Int 111:67–73CrossRefPubMed
14.
Zurück zum Zitat Sun M, Bianchi M, Hansen J et al (2012) Chronic kidney disease after nephrectomy in patients with small renal masses: a retrospective observational analysis. Eur Urol 62:696–703CrossRefPubMed Sun M, Bianchi M, Hansen J et al (2012) Chronic kidney disease after nephrectomy in patients with small renal masses: a retrospective observational analysis. Eur Urol 62:696–703CrossRefPubMed
15.
Zurück zum Zitat KDOQI (2007) KDOQI clinical practice guideline and clinical practice recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target. Am J Kidney Dis 50(3):471–530CrossRef KDOQI (2007) KDOQI clinical practice guideline and clinical practice recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target. Am J Kidney Dis 50(3):471–530CrossRef
16.
Zurück zum Zitat Xue JL, Daniels F, Star RA et al (2006) Incidence and mortality of acute renal failure in Medicare beneficiaries, 1992 to 2001. J Am Soc Nephrol 17:1135–1142CrossRefPubMed Xue JL, Daniels F, Star RA et al (2006) Incidence and mortality of acute renal failure in Medicare beneficiaries, 1992 to 2001. J Am Soc Nephrol 17:1135–1142CrossRefPubMed
17.
Zurück zum Zitat Mehrotra A, Rose C, Pannu N, Gill J, Tonelli M, Gill JS (2012) Incidence and consequences of acute kidney injury in kidney transplant recipients. Am J Kidney Dis 59:558–565CrossRefPubMed Mehrotra A, Rose C, Pannu N, Gill J, Tonelli M, Gill JS (2012) Incidence and consequences of acute kidney injury in kidney transplant recipients. Am J Kidney Dis 59:558–565CrossRefPubMed
18.
Zurück zum Zitat D’Agostino RB Jr (1998) Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 17:2265–2281CrossRefPubMed D’Agostino RB Jr (1998) Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 17:2265–2281CrossRefPubMed
19.
Zurück zum Zitat Ho DE, Imai K, King G, Stuart E (2003) MatchIt: nonparametric preprocessing for parametric causal inference. J Stat Softw 42:11–19 Ho DE, Imai K, King G, Stuart E (2003) MatchIt: nonparametric preprocessing for parametric causal inference. J Stat Softw 42:11–19
21.
Zurück zum Zitat Takaki H, Soga N, Kanda H et al (2014) Radiofrequency ablation versus radical nephrectomy: clinical outcomes for stage T1b renal cell carcinoma. Radiology 270:292–299CrossRefPubMed Takaki H, Soga N, Kanda H et al (2014) Radiofrequency ablation versus radical nephrectomy: clinical outcomes for stage T1b renal cell carcinoma. Radiology 270:292–299CrossRefPubMed
22.
Zurück zum Zitat Yang R, Lian H, Zhang G et al (2014) Laparoscopic radiofrequency ablation with intraoperative contrast-enhanced ultrasonography for T1bN0M0 renal tumors: initial functional and oncologic outcomes. J Endourol 28:4–9CrossRefPubMed Yang R, Lian H, Zhang G et al (2014) Laparoscopic radiofrequency ablation with intraoperative contrast-enhanced ultrasonography for T1bN0M0 renal tumors: initial functional and oncologic outcomes. J Endourol 28:4–9CrossRefPubMed
26.
Zurück zum Zitat Ramirez D, Ma YB, Bedir S, Antonelli JA, Cadeddu JA, Gahan JC (2014) Laparoscopic radiofrequency ablation of small renal tumors: long-term oncologic outcomes. J Endourol 28:330–334CrossRefPubMed Ramirez D, Ma YB, Bedir S, Antonelli JA, Cadeddu JA, Gahan JC (2014) Laparoscopic radiofrequency ablation of small renal tumors: long-term oncologic outcomes. J Endourol 28:330–334CrossRefPubMed
27.
Zurück zum Zitat Johnson S, Pham KN, See W, Begun FP, Langenstroer P (2014) Laparoscopic cryoablation for clinical stage T1 renal masses: long-term oncologic outcomes at the Medical College of Wisconsin. Urology 84:613–618CrossRefPubMed Johnson S, Pham KN, See W, Begun FP, Langenstroer P (2014) Laparoscopic cryoablation for clinical stage T1 renal masses: long-term oncologic outcomes at the Medical College of Wisconsin. Urology 84:613–618CrossRefPubMed
29.
Zurück zum Zitat Harris SK, Lewington AJ, Harrison DA, Rowan KM (2015) Relationship between patients’ outcomes and the changes in serum creatinine and urine output and RIFLE classification in a large critical care cohort database. Kidney Int. doi:10.1038/ki.2015.70 Harris SK, Lewington AJ, Harrison DA, Rowan KM (2015) Relationship between patients’ outcomes and the changes in serum creatinine and urine output and RIFLE classification in a large critical care cohort database. Kidney Int. doi:10.​1038/​ki.​2015.​70
Metadaten
Titel
Comparison of renal function detriments after local tumor ablation or partial nephrectomy for renal cell carcinoma
verfasst von
Alessandro Larcher
Malek Meskawi
Roger Valdivieso
Katharina Boehm
Vincent Trudeau
Zhe Tian
Nicola Fossati
Paolo Dell’Oglio
Giovanni Lughezzani
Nicolò Buffi
Maxine Sun
Pierre Karakiewicz
Publikationsdatum
01.03.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
World Journal of Urology / Ausgabe 3/2016
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-015-1606-4

Weitere Artikel der Ausgabe 3/2016

World Journal of Urology 3/2016 Zur Ausgabe

Ambulantisierung: Erste Erfahrungen mit dem Hybrid-DRG

02.05.2024 DCK 2024 Kongressbericht

Die Hybrid-DRG-Verordnung soll dazu führen, dass mehr chirurgische Eingriffe ambulant durchgeführt werden, wie es in anderen Ländern schon länger üblich ist. Die gleiche Vergütung im ambulanten und stationären Sektor hatten Niedergelassene schon lange gefordert. Aber die Umsetzung bereitet ihnen doch Kopfzerbrechen.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Harninkontinenz: Netz-Op. erfordert über lange Zeit intensive Nachsorge

30.04.2024 Harninkontinenz Nachrichten

Frauen mit Belastungsinkontinenz oder Organprolaps sind nach einer Netz-Operation keineswegs beschwerdefrei. Vielmehr scheint die Krankheitslast weiterhin hoch zu sein, sogar höher als von harninkontinenten Frauen, die sich nicht haben operieren lassen.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.